Literature DB >> 23531616

Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells.

Vimesh A Avlani1, Wenting Ma, Hee-Chang Mun, Katie Leach, Leigh Delbridge, Arthur Christopoulos, Arthur D Conigrave.   

Abstract

In addition to its acute effects on hormone secretion, epithelial transport, and shape change, the calcium-sensing receptor (CaSR) modulates the expression of genes that control cell survival, proliferation, and differentiation as well as the synthesis of peptide hormones and enzymes. In the present study, we investigated the impacts of a CaSR agonist and several CaSR modulators on phosphorylation of transcription factor CREB residue Ser(133) in CaSR-expressing HEK293 (HEK-CaSR) cells and human adenomatous parathyroid cells. Elevated Ca(2+)o concentration had no effect on CREB phosphorylation (p-CREB) in control HEK293 cells but stimulated p-CREB in both HEK-CaSR cells and human parathyroid cells. In addition, p-CREB was stimulated by the positive modulator cinacalcet and inhibited by the negative modulator NPS 2143 in both CaSR-expressing cell types. Two positive modulators that bind in the receptor's Venus Fly Trap domain, l-phenylalanine and S-methylglutathione, had no effect on p-CREB in HEK-CaSR cells, demonstrating the existence of pronounced signaling bias. Analysis of the signaling pathways using specific inhibitors demonstrated that phosphoinositide-specific phospholipase C and conventional protein kinase C isoforms make major contributions to Ca(2+)o-induced p-CREB in both cell-types, suggesting key roles for Gq/11. In addition, in parathyroid cells but not HEK-CaSR cells, activation of p-CREB was dependent on Gi/o, demonstrating the existence of cell type-specific signaling.

Entities:  

Keywords:  CREB; ERK1/2; calcilytic; calcimimetic; calcium-sensing receptor; cinacalcet; parathyroid

Mesh:

Substances:

Year:  2013        PMID: 23531616     DOI: 10.1152/ajpendo.00054.2013

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  12 in total

Review 1.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phenotypic modulation of small pulmonary arteries.

Authors:  Xue Peng; Hong-Xia Li; Hong-Jiang Shao; Guang-Wei Li; Jian Sun; Yu-Hui Xi; Hong-Zhu Li; Xin-Yan Wang; Li-Na Wang; Shu-Zhi Bai; Wei-Hua Zhang; Li Zhang; Guang-Dong Yang; Ling-Yun Wu; Rui Wang; Chang-Qing Xu
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

3.  Endothelial Restoration of Receptor Activity-Modifying Protein 2 Is Sufficient to Rescue Lethality, but Survivors Develop Dilated Cardiomyopathy.

Authors:  Daniel O Kechele; William P Dunworth; Claire E Trincot; Sarah E Wetzel-Strong; Manyu Li; Hong Ma; Jiandong Liu; Kathleen M Caron
Journal:  Hypertension       Date:  2016-07-11       Impact factor: 10.190

Review 4.  International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.

Authors:  Katie Leach; Fadil M Hannan; Tracy M Josephs; Andrew N Keller; Thor C Møller; Donald T Ward; Enikö Kallay; Rebecca S Mason; Rajesh V Thakker; Daniela Riccardi; Arthur D Conigrave; Hans Bräuner-Osborne
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 5.  Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.

Authors:  Christian Santa Maria; Zhiqiang Cheng; Alfred Li; Jiali Wang; Dolores Shoback; Chia-Ling Tu; Wenhan Chang
Journal:  Semin Cell Dev Biol       Date:  2015-12-10       Impact factor: 7.727

Review 6.  The osteocyte as a therapeutic target in the treatment of osteoporosis.

Authors:  Gaël Y Rochefort
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-06       Impact factor: 5.346

7.  Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.

Authors:  A E Cook; S N Mistry; K J Gregory; S G B Furness; P M Sexton; P J Scammells; A D Conigrave; A Christopoulos; K Leach
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

8.  A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.

Authors:  Caroline M Gorvin; Valerie N Babinsky; Tomas Malinauskas; Peter H Nissen; Anders J Schou; Aylin C Hanyaloglu; Christian Siebold; E Yvonne Jones; Fadil M Hannan; Rajesh V Thakker
Journal:  Sci Signal       Date:  2018-02-20       Impact factor: 8.192

9.  Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer's Disease.

Authors:  I Dal Prà; A Chiarini; R Pacchiana; E Gardenal; B Chakravarthy; J F Whitfield; U Armato
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

10.  A Novel Ex Vivo Method for Visualizing Live-Cell Calcium Response Behavior in Intact Human Tumors.

Authors:  James Koh; Joyce A Hogue; Julie A Sosa
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.